# Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis

> **NCT04677192** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 50 (estimated)

## Conditions studied

- Pancreatic Cancer Metastatic to Liver
- Oligometastasis

## Interventions

- **COMBINATION_PRODUCT:** Microwave Ablation combination with chemotherapy

## Key facts

- **NCT ID:** NCT04677192
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01
- **Primary completion:** 2022-01
- **Final completion:** 2022-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04677192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04677192, "Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04677192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*